Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01019629 · ClinicalTrials.gov registry record
Fabry Screening Study
A clinical trial of Fabry Disease, sponsored by Baylor Research Institute.
- Completed
- Registry status
- 2,724
- Enrollment target
- 1
- Study location
NCT01019629 is a study of Fabry Disease that has completed, run by Baylor Research Institute. The registered enrollment target is 2,724 participants, above the 458-participant average among 32 other Fabry Disease trials with a reported enrollment target (495% higher). The trial reports 1 study location across 1 state.
The verdict
NCT01019629, a study of Fabry Disease, has completed, sponsored by Baylor Research Institute.
- COMPLETED
- Registry status
- 2,724 participants
- Enrollment target
- 1
- Study location
Study Summary
To determine if patients with a deficiency of alpha-galactosidase A are at-risk for cardiac complications that commonly occur in the general population
Conditions Studied
Study Locations (1)
Texas
- Baylor Institute of Metabolic Disease - Dallas
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 2,724 participants |
| Start Date | 2009-01-29 |
| Est. Completion | 2017-12-07 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01019629
The ClinicalTrials.gov registry entry for NCT01019629 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 2,724 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 458-participant average among 32 other Fabry Disease trials with a reported enrollment target (495% higher). The listed sponsor is Baylor Research Institute, which has 180 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Fabry Disease appearing as the primary indexed condition, and to 0 interventions.
NCT01019629 reports 1 study location spanning 1 distinct geographic area - top geographies include Texas.
Frequently Asked Questions
What is clinical trial NCT01019629 about?
NCT01019629 is a clinical study titled "Fabry Screening Study". To determine if patients with a deficiency of alpha-galactosidase A are at-risk for cardiac complications that commonly occur in the general population
What is the current status of trial NCT01019629?
This trial is currently completed. The enrollment target is 2,724 participants. The study started on 2009-01-29. Estimated completion is 2017-12-07.
What conditions does trial NCT01019629 study?
This clinical trial studies the following conditions: Fabry Disease.
Who is sponsoring clinical trial NCT01019629?
This trial is sponsored by Baylor Research Institute, which has 180 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01019629 being conducted?
This trial has 1 study location across Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Fabry Disease
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Maternal and Postnatal Outcomes Study (MOS): A Global Observational Registry Assessing the Safety of Elfabrio® in Women With Fabry Disease and Their Infants During Pregnancy and Breastfeeding
RECRUITING
-
Natural History and Structural Functional Relationships in Fabry Renal Disease Treatment Outcomes(Changes)in Fabry Renal Disease Study
RECRUITING
-
A Study of Migalastat in Pediatric Subjects (2 to <12 Yrs) With Fabry Disease and Amenable GLA Variants
RECRUITING · Phase 3
-
A Study to Learn About the Safety and Effects of the Study Drug PRX-102 in Children and Adolescents With Fabry Disease
RECRUITING · Phase 2
-
A Multi-Country Observational Study of Safety and Effectiveness of Elfabrio® in Fabry Patients
RECRUITING
-
A Global Prospective Observational Study of Women With Fabry Disease and Their Infants During Pregnancy and Breastfeeding
RECRUITING
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.